Reporting owner
Torley Helen
Reporting owner CIK 0001528185 · PRESIDENT AND CEO · Director
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
8 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 8, 2026 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Oct 7, 2026 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Oct 6, 2026 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Dec 9, 2025 | HALOZYME THERAPEUTICS, INC.Performance Stock Units | Torley Helen | Stock award |
| Dec 1, 2025 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Nov 12, 2025 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Nov 11, 2025 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
| Nov 10, 2025 | HALOZYME THERAPEUTICS, INC.Common Stock | Torley Helen | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 18.41Value: 368,200Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 18.41Value: 368,200Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 18.41Value: 368,200Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Stock awardPerformance Stock UnitsDerivative security · Code A | 165,522 | 0Value: 0Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 16,569 | 8.11Value: 134,374.59Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 8.11Value: 162,200Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 8.11Value: 162,200Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Torley HelenPRESIDENT AND CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 8.11Value: 162,200Currency not specified | View ↗ |
8 transactions on this page. Filing date, newest first.